ストックスクリーナーアプリを入手
0.66
0.76%
0.005
アフターアワーズ：
.64
-0.02
-3.03%
Bone Biologics Corp (BBLG) 最新ニュース
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Bone Biologics Corporation Achieves 32-Month Validated Shelf Life For rhNELL-1 - marketscreener.com
Bone Biologics Corp expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Bone Biologics Warrants (BBLGW) Steady at $8.0 as Tight Trading Range Takes ShapeValue ETF - dars.gov.et
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This Week
Isto Biologics Acquires NovaBone | Press Release - ACCESS Newswire
Bone Biologics Warrants (BBLGW) Hold Flat at $8.00 as Range-Bound Trading PersistsMA Cross Alert - dars.gov.et
Bone Biologics Corp Warrants (BBLGW) Hold Steady at $8.0 Amid Low Volume ConsolidationBullish Sentiment - dars.gov.et
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp Warrants (BBLGW) Holds Steady at $8.0 as Consolidation Pattern EmergesMESA MA - po-news-eg.net
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Bone Biologics Corp (BBLG) Cash Flow - TradingKey
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BBLG|Bone Biologics Corp|Price:1.070|Chg%:-0.010 - TradingKey
BBLG|Bone Biologics Corp|Price:1.010|Chg%:-0.060 - TradingKey
Bone Biologics Corp (BBLG) Nears Support as Selling Pressure PersistsRetail Driven Moves - dars.gov.et
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLGW - TradingView
TradingKey - TradingKey
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics raises $3.0M in July financing, extends rhNELL-1 shelf life to 29 months - TradingView
Bone Biologics (Nasdaq: BBLG) raises $3M, extends runway to 2027 - Stock Titan
Bone Biologics extends rhNELL-1 shelf life to 29 months - Stock Titan
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities - Yahoo Finance
Bone Biologics Holds Near Support After Modest DeclineButterfly Setup - dars.gov.et
Price to book forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower-than-expected loss fails to lift stockSegment Revenue Breakdown - dars.gov.et
Form S-3 Bone Biologics Corp For: 17 July - Investing.com India
Form S-3 Bone Biologics Corp For: 17 July By Investing.com - Investing.com Nigeria
Bone Biologics (NASDAQ: BBLG) registers 6.46M warrant shares for resale - Stock Titan
Bone Biologics Corporation Files Form 8-K with SEC: Company Details, Stock Info, and Contact Information (July 2026) - Minichart
Bone postpones 2026 annual meeting to Sept. 28, sets new record date Aug. 6 - TradingView
Bone Biologics (NASDAQ: BBLG) delays 2026 meeting to September 28 - Stock Titan
World Fiber Viable Bone MatrixMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Enterprise value to revenue forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Enterprise value to EBITDA forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower Loss Surprises; Stock Holds SteadyEarnings Miss Streak - dars.gov.et
Price to sales forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Enterprise value to EBIT forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Enterprise value to revenue forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Orthobiologics Devices And Equipment Market Report 2026 Market Outlook Supported By A Forecast 8% CAGR - openPR.com
Bone Biologics Announces $9 Million Private Placement for Spine Fusion Innovation and Clinical Trials Funding 12 - Minichart
Bone Biologics Raises $2.7 Million in Private Placement; Adds $6 Million Upside From Warrants - TradingView
Bone Biologics (BBLG) raises $3M in private placement with up to $6M via warrants - Stock Titan
Bone Biologics Corp (BBLG) Edges Higher Amid Low Volume, Tests Key Resistance LevelsMonthly Profile - dars.gov.et
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Biotech Stock DeclinesGuidance vs Actual - Bölüm Sonu Canavarı
Why iOThree Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket - Benzinga
What Put Bone Biologics (NASDAQ:BBLG) on Nasdaq Composite Radar? - Kalkine Media
Bone Biologics raises $3M now, with up to $6M more from warrants - Stock Titan
Bone Biologics Announces $3 Million Private Placement Financing with Potential Additional $6 Million from Warrants - Quiver Quantitative
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance
Demineralized Bone Matrix Market Report 2026 Market Outlook Supported By A Forecast 6.3% CAGR - openPR.com
AMAT Q2 2026 Earnings: EPS Surpasses Estimates But Stock Declines Over 7%Full Year Guidance - dars.gov.et
Executive pay and board elections at Bone Biologics (NASDAQ: BBLG) - Stock Titan
Bone Biologics Corp SEC Filing (Jul 2, 2026) - Stock Titan
CISS Q3 2025 Earnings: Net Loss of $0.58 Per Share; Stock Trades at $0.61Full Year Guidance - dars.gov.et
1.80%
1.77%
大文字化:
|
ボリューム (24 時間):